Juan's Systems Biology Laboratory
From proteins to proteomics and beyond.... Aimed for drug discovery and bioenergy development; Systems & synthetic biology research
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Next revision Both sides next revision | ||
|
publication:juan [2019/10/02 04:28] 游文萱 |
publication:juan [2019/11/25 07:36] 游文萱 [Journal Papers / 期刊論文] |
||
|---|---|---|---|
| Line 2: | Line 2: | ||
| ===== Journal Papers / 期刊論文 ===== | ===== Journal Papers / 期刊論文 ===== | ||
| + | - Lee, W.-H., Chen, K.-P., Wang, K., Huang, H.-C.*, __**Juan, H.-F.**__* "Characterizing the cancer-associated microbiome with small RNA sequencing data" //Biochemical and Biophysical Research Communications// (Accepted). | ||
| - Cheung, H. Y. C., Hsu, C.-L., Tsuei, C.-Y., Kuo, T.-T., Huang, C.-T., Hsu, W.-M., Chung, Y.-H., Wu, H.-Y., Hsu, C.-C., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy" //Cell Death and Disease// (Accepted). | - Cheung, H. Y. C., Hsu, C.-L., Tsuei, C.-Y., Kuo, T.-T., Huang, C.-T., Hsu, W.-M., Chung, Y.-H., Wu, H.-Y., Hsu, C.-C., Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy" //Cell Death and Disease// (Accepted). | ||
| - Hsieh, C.-H., Cheung, C. H. Y., Liu, Y.-L., Hou, C.-L., Hsu, C.-L., Huang, C.-T., Yang, T.-S., Chen, S.-F., Chen, C.-N., Hsu, W.-M.*, Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Quantitative proteomics of Th-MYCN transgenic mice reveals aurora kinase inhibitor altered metabolic pathways and enhanced ACADM to suppress neuroblastoma progression" //Journal of Proteome Research// (Accepted). | - Hsieh, C.-H., Cheung, C. H. Y., Liu, Y.-L., Hou, C.-L., Hsu, C.-L., Huang, C.-T., Yang, T.-S., Chen, S.-F., Chen, C.-N., Hsu, W.-M.*, Huang, H.-C.*, __**Juan, H.-F.**__* (2019) "Quantitative proteomics of Th-MYCN transgenic mice reveals aurora kinase inhibitor altered metabolic pathways and enhanced ACADM to suppress neuroblastoma progression" //Journal of Proteome Research// (Accepted). | ||